A Multi-Center, Open, Randomized, Parallel-Group, 2 Arm Study to Compare the Efficacy and Safety of Insulin Add-On to Glimepiride/Metformin 1/500mg b.i.d vs. to Glimepiride 4mg qd in Type 2 DM Patients With Inadequate Glycemic Control

被引：0
|
作者：
Lee, Jae Min
Park, Kang Seo
Park, Soon Hyun
Lim, Dong Mee
Lee, Jong Min
Park, Keun Yong
Kim, Sang Jin
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1087-P
引用
收藏
页码：A280 / A281
页数：2
相关论文
共 2 条
  • [1] A multicenter, controlled, double-blind, double-dummy, randomized, two-arm parallel-group study to compare the efficacy and safety of Amaryl-M SR 2/500 mg od vs. Amaryl®-M 1/250 mg bid in patients with type 2 DM
    Kang, Mira
    Lee, Moon-Kyu
    Ahn, Chul Woo
    Baik, Sei Hyun
    Chung, Dong Jin
    Jang, Hak Chul
    Kim, Kyoung-Ah
    Lee, In-Kyu
    Min, Kyung Wan
    Nam, Moonsuk
    Park, Jong Suk
    Park, Kyongsoo
    Park, Tae Sun
    Son, Seok Man
    Sung, Yeon-Ah
    Woo, Jeong-Taek
    [J]. DIABETES, 2008, 57 : A565 - A565
  • [2] Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
    Nomoto, Hiroshi
    Takahashi, Akihiro
    Nakamura, Akinobu
    Kurihara, Hiroyoshi
    Takeuchi, Jun
    Nagai, So
    Taneda, Shinji
    Miya, Aika
    Kameda, Hiraku
    Cho, Kyu Yong
    Miyoshi, Hideaki
    Atsumi, Tatsuya
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
1